Methylene Blue Treatment of COVID-19
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fondazione Epatocentro Ticino
- Target Recruit Count
- 64
- Registration Number
- NCT04635605
- Locations
- 🇨🇭
Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland
Swiss Primary Sclerosing Cholangitis Cohort Study
- Conditions
- First Posted Date
- 2017-05-10
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fondazione Epatocentro Ticino
- Target Recruit Count
- 120
- Registration Number
- NCT03146936
- Locations
- 🇨🇭
CHUV Département femme-mère-enfant, Lausanne, Switzerland
🇨🇭Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland
🇨🇭Hôpitaux Universitaires de Genève, Centre Suisse des Maladies du foie de l'Enfant- Département de l'Enfant et de l'Adolescent, Geneve, Switzerland
Swiss Autoimmune Hepatitis Cohort Study
- Conditions
- First Posted Date
- 2017-05-10
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fondazione Epatocentro Ticino
- Target Recruit Count
- 500
- Registration Number
- NCT03146884
- Locations
- 🇨🇭
Inselspital, Bern, Switzerland
🇨🇭Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland
🇨🇭Hôpitaux Universitaires de Genève, Centre Suisse des Maladies du foie de l'Enfant- Département de l'Enfant et de l'Adolescent, Geneve, Switzerland
Swiss Primary Biliary Cholangitis Cohort Study
- Conditions
- First Posted Date
- 2017-05-10
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Fondazione Epatocentro Ticino
- Target Recruit Count
- 500
- Registration Number
- NCT03146910
- Locations
- 🇨🇭
Gastroenterologie und Hepatologie, Clarunis - Universitäres Bauchzentrum Basel, Basel, Switzerland
🇨🇭Inselspital, Bern, Switzerland
🇨🇭Hôpitaux Universitaires de Genève, Service de Gastroentérologie & Hépatologie, Département des Spécialités, Geneve, Switzerland